Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
34.06
+0.30 (0.89%)
At close: Jan 17, 2025, 4:00 PM
35.61
+1.55 (4.55%)
Pre-market: Jan 21, 2025, 5:48 AM EST
Moderna Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Moderna stock have an average target of 76.35, with a low estimate of 38 and a high estimate of 139. The average target predicts an increase of 124.16% from the current stock price of 34.06.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock from 20 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 2 | 2 | 3 | 3 | 3 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 7 | 10 | 11 | 10 | 11 | 12 |
| Sell | 0 | 1 | 1 | 2 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 16 | 17 | 19 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $70 → $38 | Hold | Maintains | $70 → $38 | +11.57% | Jan 15, 2025 |
| UBS | UBS | Strong Buy Maintains $108 → $96 | Strong Buy | Maintains | $108 → $96 | +181.86% | Jan 8, 2025 |
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 18, 2024 |
| B of A Securities | B of A Securities | Sell Initiates $41 | Sell | Initiates | $41 | +20.38% | Dec 10, 2024 |
| JP Morgan | JP Morgan | Sell Maintains $59 → $45 | Sell | Maintains | $59 → $45 | +32.12% | Nov 26, 2024 |
Financial Forecast
Revenue This Year
3.36B
from 6.85B
Decreased by -50.98%
Revenue Next Year
3.03B
from 3.36B
Decreased by -9.65%
EPS This Year
-9.47
from -12.34
EPS Next Year
-9.17
from -9.47
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.8B | 3.7B | 6.3B | |||
| Avg | 3.4B | 3.0B | 3.8B | |||
| Low | 3.0B | 2.4B | 2.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -44.0% | 11.2% | 107.1% | |||
| Avg | -51.0% | -9.7% | 25.6% | |||
| Low | -56.5% | -29.9% | -9.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -8.56 | -8.01 | -3.02 | |||
| Avg | -9.47 | -9.17 | -6.91 | |||
| Low | -10.24 | -10.14 | -8.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.